Byung Ha Chung

25PUBLICATIONS
86CO-AUTHORS
PharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Diagnostic radiographyNephrology and urologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Feb 10, 2026
Combined therapy with dutasteride and tadalafil vs dutasteride or tadalafil monotherapy in benign prostatic hyperplasia: a randomised phase III trial.

Seung Wook Lee, Seung Hwan Lee, Jae Heon Kim

|Dec 09, 2024
Prostate-specific antigen kinetics in Asian patients with metastatic castration-sensitive prostate cancer treated with apalutamide in the TITAN trial: A post hoc analysis.

Ding-Wei Ye, Hirotsugu Uemura, Byung Ha Chung

|Sep 05, 2023
A prospective, multicenter study on the clinical effectiveness of abiraterone in metastatic castration-resistant prostate cancer in Korea: Pre- vs. post-chemotherapy.

Seung-Hwan Jeong, Sang Eun Yeon, Su Youn Kim

|Aug 13, 2021
Effect of training and individual operator's expertise on prostate cancer detection through prostate biopsy: Implications for the current quantitative training evaluation system.

Dongu Lee, Byung Ha Chung, Kwang Suk Lee

|Aug 13, 2021
Optimal duration of preoperative antibiotic treatment prior to ureteroscopic lithotripsy to prevent postoperative systemic inflammatory response syndrome in patients presenting with urolithiasis-induced obstructive acute pyelonephritis.

Jeong Woo Yoo, Kwang Suk Lee, Byung Ha Chung

|Apr 29, 2021
Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study.

Kim N Chi, Simon Chowdhury, Anders Bjartell

Pageof 5

Frequent Collaborators

9 joint publications

Kwang Suk Lee

8 joint publications

Kyo Chul Koo

7 joint publications

Koon Ho Rha

4 joint publications

Young Deuk Choi